Miahelsa Holdings Corporation Q1 FY2026 earnings call

• Consolidated Overall Performance

  • Total consolidated revenue was 5.987 billion yen, 4.4% higher than the prior year period, and operating profit of 53 million yen represented a 44.6% year-over-year decline. Both top and bottom-line results significantly outperformed the original quarterly guidance.
  • Revenue growth was driven by new store openings in pharma and new nursery openings/official price hikes in child-rearing support, while profit declines stemmed from upfront investment costs and increased wage expenses across segments.

• Key Strategic Updates

  • The company is shifting its pharmacy portfolio away from large hospital front (gate) pharmacies, which face steady patient volume declines due to the national policy of 'reverse referral' that redirects patients from large hospitals to local clinics, toward lower-ASP clinic mall-style pharmacies. This shift is already delivering steady prescription volume growth, offsetting gate pharmacy declines.
  • The company began splitting KPI disclosure for gate pharmacies (25 locations) and other pharmacies (19 locations, including clinic mall stores) to improve transparency around this strategic shift.
  • Profitability improvement initiatives in nursing care, including 2025 fiscal year unprofitable location closures, have successfully returned the segment to full-year black ink profitability.

1. Pharmaceutical Business: Revenue increased 3.4% year-over-year, while segment profit decreased 42.9% year-over-year. Total prescription volumes rose 5.7% year-over-year, driven by 3 new store openings, though prescription average selling price (ASP) fell 2.4% year-over-year due to drug price revisions and the strategic shift to lower-ASP clinic mall-style pharmacies. New store opening-related costs increased by 43 million yen year-over-year. This segment accounts for the majority of consolidated revenue growth. 2. Child-rearing Support Business: Revenue increased 7.2% year-over-year, while segment profit decreased 5.4% year-over-year. Total number of children increased by 122 year-over-year (259 from 2 new authorized nurseries opened in 2024 September and 2025 April, offset by a 137-person decline at existing nurseries due to falling birth rates). The segment benefited from a 2024 government increase in official nursery pricing. This segment contributes roughly a quarter of consolidated revenue. 3. Nursing Care Business: Revenue decreased 0.8% year-over-year following the closure and divestment of unprofitable locations in the 2025 March fiscal year. Segment profit turned positive at 6 million yen, a 19 million yen improvement from a 12 million yen deficit in the year-ago quarter. Service-added high-rise senior housing occupancy remained at high levels, while day care utilization rose 2.5% year-over-year to 75.5% capacity, up 1.9 percentage points year-over-year.

• Management maintained the full-year 2026 March fiscal year original guidance for all metrics (revenue, operating profit, ordinary profit, net profit) despite the significant first quarter outperformance versus expectations.
  • Full-year revenue progress through the first quarter reached 25.1%, in line with the 25% quarterly target, while operating and ordinary profit progress hit just over 10% (which management notes is aligned with the original guidance that projected a first quarter loss).
  • Management stated it aims to build on the strong first quarter start to deliver steady revenue and profit growth through the remainder of the fiscal year.

• Falling birth rates create persistent downward pressure on enrollment at existing child-rearing support business locations, partially offsetting growth from new nursery openings.
  • The national policy of shifting patient care from large hospitals to local clinics creates steady volume declines for the company's legacy large hospital gate pharmacy portfolio, requiring continued strategic reallocation of capital to new clinic mall-style locations.
  • April 2025 national drug price revisions created downward pressure on pharmaceutical segment prescription ASP and profitability, alongside upfront investment costs for new store openings.
  • Wage improvement initiatives to retain qualified nursery staff created upward pressure on child-rearing support segment operating costs and reduced near-term profitability.
  • The occupancy decrease at オアシス東新小岩 (Oasis Higashi-Shinkoiwa) senior housing was caused by a 15-unit capacity expansion; the company is currently strengthening occupancy sales efforts to fill the new units.

No question and answer section was included in the provided earning call transcript.